Home » Topics » Medical technology

Medical technology
RSS

Catalyst Partners with Centocor for Engineered Protease Drugs

Jan. 8, 2008

By Jennifer Boggs

Dimon Urges Attendees to Push for Comprehensive New Policies

Jan. 8, 2008

By Holland Johnson

Agreements roundup: Antares Pharma, Teva partner to develop disposable injector

Jan. 8, 2008

Deals roundup: Boston Sci spins Advanced Bio control, also Prochymal rights

Jan. 8, 2008

Financings roundup: Aragon raises $25M ‘B’ financing; Benvenue closes $15M ‘B’ round

Jan. 8, 2008

Financings Roundup

Jan. 8, 2008

Dimon: ‘be prepared’ for worst, ‘have confidence ... to do well’

Jan. 8, 2008

By Holland Johnson

Illumina reorganizes, creates life science, diagnostics units

Jan. 7, 2008

Money Raised

Jan. 7, 2008

Stock Winners and Losers For The Week

Jan. 7, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...